ropsacitinib, also known as PF-06826647 and Tyk2-IN-8, is an orally administered, tyrosine kinase 2 (TYK2) inhibitor, that is in development with Pfizer for the treatment of plaque psoriasis and inflammatory bowel disease.
产品名:Ropsacitinib
货号:orb1910387
产品中文名:Ropsacitinib
产品详情链接:https://www.biorbyt.com/ropsacitinib-orb1910387.html